Vivos Therapeutics (VVOS) EPS (Diluted) Growth (1y) (2023 - 2026)
Vivos Therapeutics (VVOS) EPS (Diluted) Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 13.96% |
| 10 | Vivos Therapeutics | 5.18 Mn | 3.38 Mn | 2.95 Mn | 43.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.77% |
| Dec 31, 2025 | -17.77% |
| Sep 30, 2025 | -24.55% |
| Jun 30, 2025 | 7.72% |
| Mar 31, 2025 | 72.43% |
| Dec 31, 2024 | -107.48% |
| Sep 30, 2024 | 77.38% |
| Jun 30, 2024 | 87.05% |
| Mar 31, 2024 | 5.16% |
| Dec 31, 2023 | 216.14% |
| Sep 30, 2023 | 72.67% |
| Jun 30, 2023 | 43.91% |